| Brenda N Hayakawa, MD | |
|
1350 W Covina Blvd, San Dimas, CA 91773-3245 | |
| (909) 599-6811 | |
| (818) 587-2493 |
| Full Name | Brenda N Hayakawa |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 38 Years |
| Location | 1350 W Covina Blvd, San Dimas, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679527386 | NPI | - | NPPES |
| 00G638030 | Other | CA | BLUE SHIELD |
| 930096375 | Other | CA | RAILROAD MEDICARE |
| 00G638030 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G63803 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Emanate Health Inter-community Hospital | Covina, CA | Hospital |
| Emanate Health Foothill Presbyterian Hospital | Glendora, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cep America - California | 6103739131 | 954 |
News Archive
Over the past month, Dr. Richard Besdine and his wife have been discussing whether to see family and friends indoors this fall and winter.
AFFiRiS AG's clinical Alzheimer's vaccine candidate AD02 has already progressed to phase II clinical testing. It may therefore be possible to confirm the efficacy of the vaccine as early as during 2012. Indeed the start of this efficacy study comes only five months after the completion of the corresponding phase I study. The company is active in several disease areas and is currently developing a total of twelve prospective products in all stages of the development pipeline up to clinical phase II.
A small group of patients with a common heart defect who were treated for varicose veins with an injectable microfoam experienced no neurological, visual or cardiac changes as a result of the treatment, according to preliminary results from a phase II trial.
The New York Times reports that safety rules for biotechnology workers sometimes expose them to dangerous pathogens. "Whether handling deadly pathogens for biowarfare research, harnessing viruses to do humankind's bidding or genetically transforming cells to give them powers not found in nature, the estimated 232,000 employees in the nation's most sophisticated biotechnology labs work amid imponderable hazards. And some critics say the modern biolab often has fewer federal safety regulations than a typical blue-collar factory."
› Verified 8 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548667843 PECOS PAC ID: 6103739131 Enrollment ID: O20040121000458 |
News Archive
Over the past month, Dr. Richard Besdine and his wife have been discussing whether to see family and friends indoors this fall and winter.
AFFiRiS AG's clinical Alzheimer's vaccine candidate AD02 has already progressed to phase II clinical testing. It may therefore be possible to confirm the efficacy of the vaccine as early as during 2012. Indeed the start of this efficacy study comes only five months after the completion of the corresponding phase I study. The company is active in several disease areas and is currently developing a total of twelve prospective products in all stages of the development pipeline up to clinical phase II.
A small group of patients with a common heart defect who were treated for varicose veins with an injectable microfoam experienced no neurological, visual or cardiac changes as a result of the treatment, according to preliminary results from a phase II trial.
The New York Times reports that safety rules for biotechnology workers sometimes expose them to dangerous pathogens. "Whether handling deadly pathogens for biowarfare research, harnessing viruses to do humankind's bidding or genetically transforming cells to give them powers not found in nature, the estimated 232,000 employees in the nation's most sophisticated biotechnology labs work amid imponderable hazards. And some critics say the modern biolab often has fewer federal safety regulations than a typical blue-collar factory."
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brenda N Hayakawa, MD Po Box 4419, Woodland Hills, CA 91365-4419 Ph: (800) 358-9787 | Brenda N Hayakawa, MD 1350 W Covina Blvd, San Dimas, CA 91773-3245 Ph: (909) 599-6811 |
News Archive
Over the past month, Dr. Richard Besdine and his wife have been discussing whether to see family and friends indoors this fall and winter.
AFFiRiS AG's clinical Alzheimer's vaccine candidate AD02 has already progressed to phase II clinical testing. It may therefore be possible to confirm the efficacy of the vaccine as early as during 2012. Indeed the start of this efficacy study comes only five months after the completion of the corresponding phase I study. The company is active in several disease areas and is currently developing a total of twelve prospective products in all stages of the development pipeline up to clinical phase II.
A small group of patients with a common heart defect who were treated for varicose veins with an injectable microfoam experienced no neurological, visual or cardiac changes as a result of the treatment, according to preliminary results from a phase II trial.
The New York Times reports that safety rules for biotechnology workers sometimes expose them to dangerous pathogens. "Whether handling deadly pathogens for biowarfare research, harnessing viruses to do humankind's bidding or genetically transforming cells to give them powers not found in nature, the estimated 232,000 employees in the nation's most sophisticated biotechnology labs work amid imponderable hazards. And some critics say the modern biolab often has fewer federal safety regulations than a typical blue-collar factory."
› Verified 8 days ago
James V Pagano, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1350 W Covina Blvd, San Dimas, CA 91773 Phone: 909-599-6811 Fax: 818-587-2493 | |
Nadine Konia, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1350 W Covina Blvd, San Dimas, CA 91773 Phone: 909-599-6811 Fax: 818-587-2493 | |
Dr. Corbett G Peek, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1350 W Covina Blvd, San Dimas, CA 91773 Phone: 909-599-6811 | |
Ray Zhao, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1350 W Covina Blvd, San Dimas, CA 91773 Phone: 626-872-3457 | |
Glenn I Kane, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1350 W Covina Blvd, San Dimas, CA 91773 Phone: 909-599-6811 Fax: 818-587-2493 | |
Bruce M Hensel, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1350 W Covina Blvd, San Dimas, CA 91773 Phone: 909-599-6811 Fax: 818-587-2493 |